13.2 Atopic dermatitis Atopic dermatitis alleviation by ginsenoside Rh1 was investigated in an oxazolone-induced atopic dermatitis-like skin lesion model via oral administration at 20 mg/kg or 10 mg/kg [220]
Overall, these data suggest a relatively understudied connection between dopaminergic modulation of immune function and bipolar disorder and indicate that the combination of anti-inflammatory and dopaminergic drugs could provide more beneficial alleviation of bipolar symptomatology than individual treatment
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
The good, the bad, and the ugly of ROS: New insights on aging and aging-related diseases from eukaryotic and prokaryotic model organisms
